Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Vaccines

Free Subscription Articles published in AIDS Retrieve available abstracts of 20 articles: HTML format

Single Articles

October 2022
1. CHAMBERS C, Samji H, Cooper CL, Costiniuk CT, et al
   COVID-19 Vaccine Effectiveness among a Population-based Cohort of People Living with HIV.
   AIDS. 2022 Oct 19. pii: 00002030-990000000-00126.
   PubMed     Abstract available
   
   
   
2. WONG NS, Wong BCK, Chan JMC, Wong KH, et al
   Humoral responses to coronavirus disease 2019 vaccines in people with HIV: authors' reply.
   AIDS. 2022;36:1747-1748.
   PubMed    
   
   
   
3. MUNGMUNPUNTIPANTIP R, Wiwanitkit V
   Surrogate neutralization responses following SARS-CoV-2 vaccination in people with HIV.
   AIDS. 2022;36:1746-1747.
   PubMed    
   
   
   August 2022
4. THINDWA D, Mwalukomo TS, Msefula J, Jambo KC, et al
   Risk factors for pneumococcal carriage in adults living with HIV on antiretroviral therapy in the infant pneumococcal vaccine era in Malawi.
   AIDS. 2022 Aug 22. pii: 00002030-990000000-00094.
   PubMed     Abstract available
   
   
   
5. CHAMMARTIN F, Kusejko K, Pasin C, Trkola A, et al
   Determinants of antibody response to severe acute respiratory syndrome coronavirus 2 mRNA vaccines in people with HIV.
   AIDS. 2022;36:1465-1468.
   PubMed     Abstract available
   
   
   July 2022
6. GIANSERRA L, Dona MG, Giuliani E, Stingone C, et al
   High seroconversion rate after vaccination with mRNA BNT162b2 vaccine against SARS-CoV-2 among people with HIV - but HIV viremia matters?
   AIDS. 2022;36:1319-1320.
   PubMed    
   
   
   
7. WOLDEMESKEL BA, Karaba AH, Garliss CC, Beck EJ, et al
   Decay of coronavirus disease 2019 mRNA vaccine-induced immunity in people with HIV.
   AIDS. 2022;36:1315-1317.
   PubMed     Abstract available
   
   
   
8. CRUM NF, Ahmad A
   Immunity against measles in people with HIV: the need for more research and surveillance.
   AIDS. 2022;36:1305-1306.
   PubMed    
   
   
   June 2022
9. POURCHER V, Belin L, Soulie C, Rosenzwajg M, et al
   High seroconversion rate and SARS-CoV-2 Delta neutralization in PLWHIV vaccinated with BNT162b2.
   AIDS. 2022 Jun 23. pii: 00002030-990000000-00043.
   PubMed     Abstract available
   
   
   April 2022
10. WONG NS, Wong BCK, Chan JMC, Wong KH, et al
    Surrogate neutralisation responses following SARS-CoV-2 vaccination in people living with HIV - comparison between inactivated and mRNA vaccine.
    AIDS. 2022 Apr 23. pii: 00002030-990000000-00010.
    PubMed     Abstract available
    
    
    March 2022
11. LEFEBVRE M, Secher S, Bouchez S, Vandamme YM, et al
    Measles seroprevalence in human immunodeficiency virus-infected adults born in the era of measles vaccination.
    AIDS. 2022 Mar 8. pii: 00002030-990000000-00002.
    PubMed     Abstract available
    
    
    
12. XU X, Vesterbacka J, Aleman S, Nowak P, et al
    High seroconversion rate after vaccination with mRNA BNT162b2 vaccine against SARS-CoV-2 among people with HIV - but HIV viremia matters?
    AIDS. 2022;36:479-481.
    PubMed     Abstract available
    
    
    February 2022
13. DURIER C, Mercier-Delarue S, Verdiere NC, Meiffredy V, et al
    A 5-year neutralizing immune response to yellow fever vaccine in HIV-infected and HIV-uninfected adults.
    AIDS. 2022;36:319-321.
    PubMed    
    
    
    
14. SHAVER ZM, Anderson M, Bhebhe L, Baruti K, et al
    Decreased HBV vaccine response among HIV positive infants compared to HIV negative infants in Botswana.
    AIDS. 2022 Feb 1. pii: 00002030-900000000-96228.
    PubMed     Abstract available
    
    
    January 2022
15. HASSOLD N, Brichler S, Ouedraogo E, Leclerc D, et al
    Impaired antibody response to COVID-19 vaccination in advanced HIV infection.
    AIDS. 2022 Jan 10. pii: 00002030-900000000-96241.
    PubMed     Abstract available
    
    
    
16. ALEDO MG, Canizares A, Vazquez-Rodriguez P, Castro A, et al
    Safety and immunogenicity of SARS-CoV-2 mRNA-1273 and BNT162b2 vaccines in people living with HIV.
    AIDS. 2022 Jan 6. pii: 00002030-900000000-96246.
    PubMed     Abstract available
    
    
    December 2021
17. SPINELLI MA, Brown LB, Glidden DV, Hunter K, et al
    SARS-CoV-2 incidence, testing rates, and severe COVID-19 outcomes among people with and without HIV.
    AIDS. 2021;35:2545-2547.
    PubMed     Abstract available
    
    
    November 2021
18. MOHAPI L, Pinedo Y, Osiyemi O, Supparatpinyo K, et al
    Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV: a randomized phase 3 study.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96271.
    PubMed     Abstract available
    
    
    August 2021
19. MARASINI B, Vyas HK, Lakhashe SK, Hariraju D, et al
    Mucosal AIDS virus transmission is enhanced by antiviral IgG isolated early in infection.
    AIDS. 2021 Aug 16. pii: 00002030-900000000-96332.
    PubMed     Abstract available
    
    
    June 2021
20. LIU G, Mugo NR, Brown ER, Mgodi NM, et al
    Prevalent HPV infection increases the risk of HIV acquisition in African women: advancing the argument for HPV immunization.
    AIDS. 2021 Jun 24. pii: 00002030-900000000-96360.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: